<?xml version="1.0" encoding="UTF-8"?>
<svg height="777.49" width="545.193" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M49.610 53.720 L532.910 53.720 "/>
  <g begin="text">
   <text y="49.34" x="49.606,54.606,59.606,64.606" svgx:width="0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">444 </text>
   <text y="49.34" x="438.646,443.126,447.606,451.146,453.956,458.336,461.466,464.246,468.826,473.206,476.746,480.286,482.166,486.646,491.336,494.116,499.326,501.306,504.086,509.296,514.506,517.286,520.206,524.786,529.996" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1)</text>
  </g>
  <g begin="text">
   <text y="767.49" x="49.606,57.736,62.426,64.306,67.116,68.996,73.896,75.776,80.156,82.936,87.516,91.366,93.246,97.626,100.756,105.236,108.776,110.656,114.196,116.976,119.376,123.856,128.546,131.676,136.366,141.056" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="767.49" x="142.936,145.716,150.716,155.716,160.716,165.716,167.906,170.686,175.686,180.686,182.876,185.656,188.886,193.466,198.466,201.696,204.476,209.476,214.476,219.476,224.476,229.476,234.476" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285â€“496</text>
  </g>
  <g begin="text">
   <text y="767.42" x="466.181,473.891,477.741,479.931,482.121,485.971,490.241,494.511,499.301,504.301,509.301,514.201,516.391,520.771,526.291" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M49.610 413.300 L87.340 413.300 "/>
  <g begin="text">
   <text y="77.103" x="49.606,54.106,56.608,60.109,64.105,68.605,73.105,75.607,78.109,82.609,87.109,91.105,93.607,96.109,100.609,105.109,108.025,114.523,118.519,121.516,125.512,128.014,130.93,135.43,138.427,142.423,146.923,151.423,155.419,159.919,163.915,168.415,171.331,173.833,178.333,181.249,185.749,188.665,193.165,197.161,199.663,202.165,206.161,210.661,213.163,216.664,218.914,221.83,226.33,228.832,233.332,237.832,240.748,245.752,253.753,258.919,261.835,264.832,267.334,270.835,275.335,278.251,280.753,285.253" svgx:width="0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.28,0.25,0.5,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.5,0.28,0.5,0.5,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">discontinuation were: pregnancy in 6 patients, high PML risk in </text>
   <text y="88.101" x="49.606,54.106,58.606,60.856,63.106,64.186,69.19,71.692,74.689,77.191,81.691,84.688,88.684,91.186,95.686,100.186,102.688,104.938,106.018,110.518,114.514,117.016,119.518,123.514,128.014,130.516,134.017,136.267,137.347,143.845,147.841,150.838,154.834,157.084,158.164,161.665,168.163,170.665,173.167,177.163,181.663,185.659,190.159,192.409,193.489,195.991,200.491,202.741,203.821,208.321,210.823,215.323,219.319,222.316,224.566,225.646,228.148,232.648,236.644,239.641,243.637,248.137,250.639,254.635,258.136,260.386,261.466,265.462,268.459,270.961,274.957,277.954,280.204,281.284,285.28" svgx:width="0.5,0.5,0.25,0.25,0.55,0.56,0.28,0.33,0.28,0.5,0.33,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">60. Fifty-eight patients were switched to other therapies after a </text>
   <text y="99.099" x="49.606,52.108,56.608,59.605,63.601,67.597,69.847,71.899,78.901,83.401,87.901,90.403,94.903,97.9,104.398,108.394,111.895,116.395,120.895,125.395,127.897,130.147,132.199,136.699,140.695,143.692,146.194,150.694,155.194,157.696,159.946,161.998,166.498,170.998,173.248,175.3,178.801,185.299,187.801,190.303,194.299,198.799,202.795,207.295,209.545,211.597,214.099,218.599,220.849,222.901,225.898,228.4,232.9,237.4,241.9,244.402,246.904,253.906,258.406,262.906,265.156,267.406,269.458,273.958,276.208,278.26,280.762,285.262" svgx:width="0.28,0.5,0.33,0.44,0.44,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.33,0.72,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.55,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">three month-washout period: 50 switched to fingolimod, 6 to </text>
   <text y="110.097" x="49.606,52.108,56.608,59.11,63.106,66.103,69.1,73.096,76.093,80.593,85.093,87.343,89.8,94.3,98.296,100.798,104.794,107.044,109.501,112.498,115.495,120.499,126.997,131.497,134.494,136.744,138.994,141.46,145.96,148.21,150.667,153.169,157.669,159.919,162.385,166.381,170.881,174.877,177.379,181.879,186.379,190.879,195.379,198.88,203.38,207.88,211.876,218.878,221.38,225.88,229.876,232.126,234.376,236.671,241.54,248.038,252.538,254.788,257.254,261.754,265.75,268.252,270.754,274.75,279.25,281.752,285.253" svgx:width="0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.33,0.33,0.56,0.72,0.5,0.33,0.25,0.25,0.55,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.78,0.28,0.5,0.44,0.25,0.25,0.55,0.61,0.72,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">interferon beta (IFNb), 2 to cyclophosphamide. Two patients </text>
   <text y="121.095" x="49.606,52.603,56.599,63.601,67.597,70.099,74.599,78.595,83.095,85.687,88.189,92.689,96.685,99.682,103.678,108.178,112.678,115.27,118.267,121.264,125.26,129.256,131.506,133.603,140.101,142.603,145.105,147.697,150.199,154.699,158.695,161.287,165.787,169.783,172.285,174.787,178.783,183.283,185.785,189.286,191.878,198.376,202.372,205.369,209.365,211.957,214.954,219.454,221.956,224.458,228.958,235.456,239.452,243.952,246.544,249.541,254.041,257.038,259.63,263.626,266.128,268.72,271.222,275.218,279.214,282.715,285.217" svgx:width="0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.33,0.33,0.44,0.44,0.25,0.25,0.72,0.28,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">remained therapy free. All the patients were followed for at least </text>
   <text y="132.093" x="49.606,53.107,55.609,60.109,62.206,69.208,73.708,78.208,80.71,85.21,88.711,90.808,97.306,99.808,102.31,106.81,108.907,115.909,120.409,124.909,127.411,131.911,134.413,138.913,141.01,145.006,147.508,150.01,154.51,157.012,161.008,165.004,167.506,169.603,173.599,178.099,182.095,189.097,191.599,196.099,200.095,202.597,205.099,209.599,214.099,216.196,220.192,224.692,229.192,231.289,235.789,238.786,242.782,245.284,249.784,251.881,259.882,265.885,268.882,270.979,275.479,279.475,282.265" svgx:width="0.39,0.28,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.78,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.89,0.67,0.33,0.25,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">six months with monthly clinical examination and brain MRI per-</text>
   <text y="143.091" x="49.606,52.603,57.103,60.1,67.102,71.098,75.598,77.848,82.348,86.344,89.341,93.841,96.838,100.834,103.084,106.585,109.087,113.083,116.08,118.582,121.084,125.584,130.084,132.334,134.836,139.336,143.332,145.582,150.082,154.078,160.576,162.826,165.328,169.828,173.824,176.821,180.817,185.317,189.817,192.067,196.063,200.563,205.063,207.313,209.815,214.315,216.565,220.561,224.557,228.058,232.054,234.304,238.804,241.801,244.051,247.048,251.044,253.546,257.542,262.042,265.543,269.539" svgx:width="0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.39,0.28,0.44,0.33,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.72,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">formed before starting the new therapy and in case of relapse.</text>
   <text y="154.089" x="49.606,56.104,60.1,63.601,68.605,71.107,74.104,77.605,80.602" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="154.089" x="82.708,88.711,92.707,95.209,101.707,105.703,109.699,114.199,116.305,123.307,127.807,132.307,134.809,139.309,141.415,145.915,148.021,152.017,156.517,161.017,163.123,167.623,169.729,173.725,176.722,179.224,183.22,186.217,188.323,192.823,196.819,199.321,203.317,205.819,208.321,212.317,216.817,223.819,227.815,232.315,234.421,238.921,241.918,245.914,249.91,254.41,256.66,258.766,262.762,265.264,267.766,272.266,274.768,278.764,282.76,285.262" svgx:width="0.67,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.5,0.33,0.44,0.44,0.5,0.25,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Between month 4 and 6 after natalizumab break, clinical </text>
   <text y="165.087" x="49.606,53.602,58.102,62.602,65.104,69.604,72.601,74.851,79.387,83.887,87.883,92.383,95.38,99.88,102.382,109.384,113.38,117.88,120.382,124.882,129.382,131.632,136.168,140.164,144.664,147.166,151.666,155.662,160.162,164.158,168.154,170.404,174.94,179.44,182.437,184.687,189.223,193.723,196.225,199.726,203.722,207.718,211.219,215.215,217.465,222.001,224.998,228.994,232.99,236.986,239.488,241.99,246.49,250.486,252.988,255.49,259.99,264.49,266.74,271.276,277.774,281.77,285.271" svgx:width="0.44,0.5,0.5,0.28,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.28,0.78,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and/or neuroimaging evidence of disease reactivation was </text>
   <text y="176.085" x="49.606,54.106,58.606,62.107,66.103,69.1,73.6,77.596,82.096,84.751,87.253,91.753,94.408,98.908,103.408,107.908,115.405,118.06,121.057,126.061,132.559,137.059,140.056,142.558,145.555,149.551,153.547,156.049,160.045,164.545,166.795,169.45,173.95,178.45,185.947,188.602,191.599,196.099,200.599,203.101,207.601,212.101,215.098,217.753,220.75,223.252,227.752,232.252,236.752,239.254,241.756,248.758,253.258,257.758,260.755,263.257,266.254,270.25,274.246,276.748,280.744,285.244" svgx:width="0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.83,0.25,0.33,0.56,0.72,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.25,0.5,0.5,0.83,0.25,0.33,0.5,0.5,0.28,0.5,0.5,0.33,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">observed in 100% IFNb-treated, 44% (22/50) fingolimod-treated </text>
   <text y="187.083" x="49.606,53.602,58.102,62.602,64.852,65.95,70.45,74.95,79.45,86.947,89.197,90.295,94.291,98.791,102.787,105.289,109.789,114.289,118.789,123.289,126.79,131.29,135.79,139.786,146.788,149.29,153.79,157.786,160.783,163.285,166.282,170.278,174.274,176.776,180.772,185.272,187.522,188.62,193.12,197.116,199.618,202.12,206.116,210.616,213.118,216.619,218.869,221.119,222.217,228.715,231.712,233.962,235.06,237.562,242.062,246.058,248.308,249.406,253.906,256.156,257.254,260.251,264.247,271.249,275.245,277.747,281.743,285.244" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.83,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.78,0.28,0.5,0.44,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.72,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 100% cyclophosphamide-treated patients. Of the 6 females </text>
   <text y="198.081" x="49.606,52.108,56.608,60.604,63.106,65.113,69.613,72.115,76.111,80.611,85.111,89.107,93.607,95.614,100.114,103.111,107.107,111.607,116.107,120.103,124.603,128.599,132.514,134.764,136.771,141.271,143.278,147.778,151.774,156.274,158.281,162.277,164.284,171.286,173.788,176.29,180.79,182.797,187.297,189.799,193.3,197.296,201.292,204.793,208.789,210.796,213.793,217.789,221.785,225.781,228.283,230.785,235.285,239.281,241.783,244.285,248.785,253.285,255.292,259.792,263.788,266.29,272.788,276.784,280.78,285.28" svgx:width="0.28,0.5,0.44,0.28,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.5,0.25,0.5,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.5,0.25,0.5,0.44,0.5,0.25,0.44,0.25,0.78,0.28,0.28,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">that planned pregnancy, 3 had a mild disease reactivation between </text>
   <text y="209.079" x="49.606,56.608,61.108,65.608,68.11,72.61,76.111,78.127,82.627,84.643,88.639,93.139,97.639,99.655,104.155,106.405,108.421,114.919,119.419,121.921,124.423,128.419,130.435,132.937,137.437,140.434,144.43,148.426,150.442,153.439,157.435,164.437,168.433,170.935,175.435,179.431,183.931,185.947,190.447,192.949,196.45,200.446,204.442,207.943,211.939,213.955,216.952,219.949,223.945,227.941,230.191,232.207,238.21,242.71,245.212,249.712,251.728,256.228,260.728,263.23,266.227,270.223,274.219,276.721,280.717,285.217" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.25,0.28,0.5,0.33,0.44,0.44,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.33,0.33,0.44,0.44,0.25,0.25,0.67,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months 4 and 5, while three remained disease free. Both untreated </text>
   <text y="220.077" x="49.606,54.106,58.102,60.604,63.106,67.102,71.602,74.104,77.605,80.485,83.482,87.478,89.98,93.976,98.476,101.977,105.973,110.473,112.723,115.108,121.606,124.108,126.61,129.49,131.992,136.492,140.992,144.988,147.49,151.99,155.986,158.623,160.873,163.753,168.253,172.753,175.255,179.755,184.255,187.135,190.132,194.632,199.132,206.629,209.626,212.506,217.006,221.002,223.504,226.006,230.002,234.502,237.004,240.505,243.385,247.885,251.881,256.381,259.261,263.761,266.263,269.764,273.76,277.756,281.257,285.253" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.5,0.25,0.25,0.72,0.28,0.28,0.25,0.28,0.5,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.25,0.5,0.5,0.28,0.5,0.5,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients relapsed. All together, 35/66 (53%) patients had disease </text>
   <text y="231.075" x="49.606,52.603,56.599,60.595,64.591,67.093,69.595,74.095,78.091,80.593,83.095,87.595,92.095" svgx:width="0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reactivation.</text>
   <text y="242.073" x="49.606,56.104,60.604,65.608,69.604,72.106,77.11,80.611,83.113,87.613,92.617,96.118,99.115" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="242.073" x="102.688,109.186,113.686,116.683,118.933,120.256,124.756,129.256,132.757,136.753,139.75,144.25,148.246,150.748,153.25,157.75,162.25,165.751,168.001,169.324,172.825,175.327,178.324,182.824,187.324,191.824,194.326,198.826,201.076,202.399,206.395,210.895,215.395,218.392,220.894,223.891,230.893,233.143,234.466,236.968,241.468,245.464,247.966,250.216,252.466,253.789,256.291,260.791,265.291,269.287,273.787,277.783,282.283" svgx:width="0.72,0.5,0.33,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.39,0.28,0.33,0.5,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our observations strongly confirm that, indepen-</text>
   <text y="253.071" x="49.606,54.106,58.102,62.602,65.104,67.606,72.106,74.356,75.598,78.595,81.592,86.092,93.094,95.344,96.586,99.088,103.588,107.584,109.834,111.076,114.577,119.077,123.577,127.078,131.074,135.574,140.074,144.07,148.57,151.072,153.322,154.564,157.066,161.566,165.562,168.559,172.555,177.055,181.051,185.551,188.053,190.555,194.551,196.801,198.043,202.543,207.043,209.545,212.047,216.547,221.047,224.548,226.798,229.048,230.29,234.286,236.536,237.778,240.28,244.78,247.777,251.773,255.769,258.019,259.261,266.263,270.763,275.263,277.765,282.265" svgx:width="0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.55,0.44,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dently from the subsequent therapeutic options, a three month-</text>
   <text y="264.069" x="49.606,56.104,60.1,63.601,68.101,72.601,77.101,79.603,81.853,84.562,88.558,91.555,94.057,98.053,101.05,103.3,106.009,110.509,114.505,117.007,121.003,123.505,126.007,130.003,134.503,141.505,145.501,150.001,152.251,154.96,157.462,160.963,163.213,165.922,170.422,174.418,178.414,182.41,185.407,189.907,194.407,198.907,202.408,204.658,207.367,210.868,213.37,217.87,221.866,225.862,228.112,230.821,233.323,235.825,238.075,240.784,244.78,249.28,253.78,258.28,261.781,265.777,269.278,271.528,274.237,276.739,281.239,285.235" svgx:width="0.72,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.5,0.44,0.44,0.44,0.33,0.5,0.5,0.5,0.39,0.25,0.55,0.39,0.28,0.5,0.44,0.44,0.25,0.55,0.28,0.28,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">washout after natalizumab is hazardous since it exposes the </text>
   <text y="275.067" x="49.606,54.106,58.102,60.604,63.106,67.102,71.602,74.104,77.605,80.413,82.915,87.415,90.223,94.219,97.027,102.103,106.603,111.103,118.6,121.408,124.405,126.907,130.408,134.908,137.716,142.216,145.213,148.021,152.521,155.023,158.524,162.52,166.516,170.017,174.013,176.821,179.818,183.814,187.81,191.806,194.308,196.81,201.31,205.306,207.808,210.31,214.81,219.31,222.118,226.618,230.614,233.116,239.614,243.61,247.606,252.106,254.914,261.916,266.416,270.916,273.418,277.918,280.726,285.226" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.44,0.25,0.56,0.5,0.5,0.83,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients to a &gt;50% risk of disease reactivation between month 4 </text>
   <text y="286.065" x="49.606,53.602,58.102,62.602,65.212,69.712,71.962,74.41,79.909,84.409,88.909,92.41,94.66,97.27,101.266,105.766,110.266,112.876,119.374,123.37,126.871,131.371,135.871,140.371,142.873,145.123,147.733,151.729,155.23,159.73,163.726,167.722,170.224,174.22,176.722,179.224,183.724,186.334,188.836,193.336,195.946,200.446,204.442,206.944,209.446,213.442,217.942,220.444,223.945,226.555,231.055,235.051,239.551,242.053,246.553,251.053,253.663,258.163,262.159,266.659,269.269,273.769,277.765,280.762,285.262" svgx:width="0.44,0.5,0.5,0.25,0.5,0.25,0.25,0.61,0.5,0.5,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.72,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.25,0.44,0.39,0.5,0.44,0.44,0.28,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.5,0.25,0.5,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 6. Thus, any washout, especially in patients having had very </text>
   <text y="297.063" x="49.606,53.602,57.598,60.1,62.602,67.102,71.098,73.438,77.938,80.44,83.941,87.937,91.933,95.434,99.43,101.77,106.27,109.267,111.769,116.269,119.266,121.606,124.108,128.608,130.948,135.448,139.444,141.946,145.942,148.444,150.946,154.942,159.442,166.444,170.44,174.94,177.19,179.53,183.031,187.531,192.031,196.531,199.033,203.533,205.873,210.373,214.369,216.709,221.209,225.205,229.705,232.207,234.547,237.049,241.549,243.889,247.885,250.225,257.227,259.729,264.229,266.731,273.733,278.233,285.235" svgx:width="0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.28,0.5,0.33,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.39,0.5,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.5,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.44,0.25,0.78,0.28,0.5,0.28,0.78,0.5,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">active disease prior to natalizumab, should be kept to a minimum </text>
   <text y="308.061" x="49.606,54.106,57.103,59.137,63.133,67.633,71.629,76.129,78.163,82.159,86.659,91.159,93.661,98.161,102.157,106.657,108.907,110.779,118.555,123.055,126.052,128.554,133.054,135.088,139.588,142.585,144.619,147.121,151.621,154.123,158.119,161.116,165.112,168.613,171.115,173.149,177.145,180.142,184.138,186.172,188.674,193.174,197.17,199.204,202.705,205.207,209.707,211.741,216.241,220.237,222.739,225.241,229.237,233.737,236.239,239.74,241.774,244.276,248.776,252.772,255.274,257.308,261.808,265.804,269.8,272.302,276.802,280.798,285.298" svgx:width="0.5,0.33,0.25,0.44,0.5,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.25,0.94,0.5,0.33,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.33,0.44,0.39,0.28,0.25,0.44,0.33,0.44,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.44,0.28,0.25,0.5,0.44,0.44,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">or even avoided. Worth of interest are the six patients that decided </text>
   <text y="319.059" x="49.606,52.108,56.608,58.858,59.947,64.447,66.949,70.945,75.445,77.695,78.784,81.286,85.786,89.782,92.032,93.121,97.621,100.618,104.614,109.114,113.614,117.61,122.11,126.106,130.606,133.108,135.358,136.447,138.949,143.449,146.446,150.442,154.438,156.688,157.777,162.277,166.273,168.775,171.277,175.273,179.773,182.275,185.776,188.026,189.115,192.112,196.108,203.11,207.106,209.608,214.108,218.104,222.604,224.854,225.943,230.443,232.945,236.446,240.442,244.438,247.939,251.935,254.932,257.929,260.926,264.922,268.918,271.168,272.257,276.253,280.753,285.253" svgx:width="0.28,0.5,0.25,0.55,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.33,0.33,0.33,0.44,0.44,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to plan the pregnancy: three patients remained disease-free and </text>
   <text y="330.057" x="49.606,52.108,56.608,59.605,63.601,67.597,69.775,74.275,78.271,82.771,84.949,91.951,94.453,96.955,101.455,103.633,106.63,110.626,113.128,117.124,121.624,125.125,129.121,132.622,134.872,137.05,139.552,144.052,148.048,152.548,154.726,158.722,161.224,163.726,165.904,168.901,172.897,179.899,183.895,186.397,190.897,194.893,199.393,201.571,205.567,209.068,213.568,220.57,225.07,227.572,232.072,239.074,243.07,245.572,248.074,252.07,254.248,256.75,261.25,264.247,268.747,273.247,277.747,282.247" svgx:width="0.28,0.5,0.33,0.44,0.44,0.25,0.5,0.44,0.5,0.25,0.78,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.28,0.5,0.44,0.5,0.25,0.44,0.28,0.28,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.44,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.44,0.28,0.28,0.44,0.25,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">three had mild relapses, than all remained asymptomatic through-</text>
   <text y="341.055" x="49.606,54.106,58.606,61.108,63.826,66.328,70.828,74.824,77.542,82.042,85.039,89.035,93.535,98.035,102.031,106.531,110.527,114.442,116.692,119.41,123.406,127.906,132.406,135.403,137.905,140.902,147.904,150.406,154.906,159.406,162.124,164.626,169.126,173.122,175.84,180.34,183.337,187.837,190.339,194.335,198.331,200.833,203.335,207.835,211.831,214.549,218.545,221.38,224.377,228.373,232.369,234.871,237.589,242.089,245.086,247.804,252.304,255.301,259.297,263.797,268.297,272.293,276.793,280.789,285.289" svgx:width="0.5,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">out the pregnancy, confirming the protective effect of pregnancy </text>
   <text y="352.053" x="49.606,53.602,58.102,62.098,66.598,68.848,71.35,75.85,78.1,82.6,86.596,89.098,91.6,95.596,100.096,102.598,106.099,108.349,114.847,117.349,119.851,124.351,126.601,131.101,135.097,138.094,140.596,143.098,147.094,151.594,154.096,158.092,161.089,163.591,168.091,170.341,174.337,178.333,180.835,183.337,187.837,191.833,194.083,202.084,207.088" svgx:width="0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.28,0.44,0.33,0.28,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">even in patients with particularly active MS.</text>
   <text y="379.053" x="49.606,55.105,59.605,64.105" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P860</text>
   <text y="390.051" x="49.606,58.102,63.106,65.356,70.855,74.356,80.854,85.858,91.861,94.111,97.108,99.358,103.858,106.108,108.61,113.11,118.114,122.614,125.116,128.113,133.117,138.121,140.623,145.627,150.127,152.629,154.879,157.129,162.133,166.129,170.629,174.13,179.134,183.13,187.126,190.123,192.625,197.125,201.121,203.371,205.621,209.617,214.117,221.614,226.618,231.118,235.114,239.614,242.611,245.113,249.613,253.609" svgx:width="0.94,0.56,0.25,0.61,0.39,0.72,0.56,0.67,0.25,0.33,0.25,0.5,0.25,0.28,0.5,0.56,0.5,0.28,0.33,0.56,0.56,0.28,0.56,0.5,0.28,0.25,0.25,0.56,0.44,0.5,0.39,0.56,0.44,0.44,0.33,0.28,0.5,0.44,0.25,0.25,0.44,0.5,0.83,0.56,0.5,0.44,0.5,0.33,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">MS FIRST - a longitudinal, prospective, comparative </text>
   <text y="401.049" x="49.606,54.61,58.606,63.61,68.11,70.36,73.861,78.361,81.358,85.354,88.351,92.851,95.101,102.598,107.098,112.102,117.106,119.608,123.604,125.854,128.851,133.351,137.347,139.597,144.601,148.102,152.098,154.348,156.85,161.854,164.104,172.6,177.604,179.854,183.85,186.352,188.854,193.858,196.36,200.356,204.856,207.358,209.608,214.612,218.608,223.108,227.104,230.101,232.603,236.599" svgx:width="0.56,0.44,0.56,0.5,0.25,0.39,0.5,0.33,0.44,0.33,0.5,0.25,0.83,0.5,0.56,0.56,0.28,0.44,0.25,0.33,0.5,0.44,0.25,0.56,0.39,0.44,0.25,0.28,0.56,0.25,0.94,0.56,0.25,0.44,0.28,0.28,0.56,0.28,0.44,0.5,0.28,0.25,0.56,0.44,0.5,0.44,0.33,0.28,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">drug safety module for use in MS clinical practice</text>
   <text y="412.047" x="49.606,53.107,55.357,61.855,65.851,69.847,72.844,75.346,78.847,82.843" svgx:width="0.39,0.25,0.72,0.44,0.44,0.33,0.28,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">J Haartsen</text>
   <text y="409.583" x="87.342" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="412.103" x="90.268,92.518,94.768,100.267,102.517,107.521,112.021,116.017,118.519,125.521,129.516" svgx:width="0.25,0.25,0.61,0.25,0.56,0.5,0.44,0.28,0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Spelman</text>
   <text y="409.583" x="134.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="412.103" x="136.941,139.191,141.441,146.94,149.19,157.191,161.691,164.688,169.188,173.184" svgx:width="0.25,0.25,0.61,0.25,0.89,0.5,0.33,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Morgan</text>
   <text y="409.583" x="177.684" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="412.103" x="180.609,182.859,185.109,190.113,192.363,198.861,203.361,205.863,209.859,214.359" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.28,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Agland</text>
   <text y="409.583" x="218.859" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="412.103" x="221.784,224.034,226.284,229.785,232.035,238.038,242.034,246.534,250.53" svgx:width="0.25,0.25,0.39,0.25,0.67,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Baker</text>
   <text y="409.583" x="253.526" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="412.103" x="256.451,258.701" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="423.101" x="49.604,57.605,59.855,65.858,69.854,74.354,76.856" svgx:width="0.89,0.25,0.67,0.44,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M Canty</text>
   <text y="420.583" x="81.358" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="423.103" x="84.283,86.533,88.783,94.282,96.532,102.535,106.531,109.033" svgx:width="0.25,0.25,0.61,0.25,0.67,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Rath</text>
   <text y="420.583" x="113.533" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">6</text>
   <text y="423.103" x="116.458,118.708,120.958,124.459,126.709,132.208,136.204,140.2,144.7,149.2,153.196,156.193,159.19,164.194,168.19,172.69,175.192" svgx:width="0.25,0.25,0.39,0.25,0.61,0.44,0.44,0.5,0.5,0.44,0.33,0.33,0.56,0.44,0.5,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Lechner-Scott</text>
   <text y="420.583" x="177.693" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="423.103" x="180.618,182.868,185.118,191.616,193.866,199.869,204.369,206.871,210.867,215.367,219.867,223.863,228.363,232.359" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.28,0.44,0.5,0.5,0.44,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, H Butzkueven</text>
   <text y="420.583" x="236.858,239.783,241.246" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4,7</text>
   <text y="423.103" x="244.171,246.421,248.671,256.672,261.676" svgx:width="0.25,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MS </text>
   <text y="434.101" x="49.609,54.613,57.61,63.613,68.617,74.116,76.366,81.37,83.872,88.372,92.872,97.372,99.622,106.12,109.117,113.617,118.117,122.617,125.119,133.12,138.124,144.127,148.123,151.624" svgx:width="0.56,0.33,0.67,0.56,0.61,0.25,0.56,0.28,0.5,0.5,0.5,0.25,0.72,0.33,0.5,0.5,0.5,0.28,0.89,0.56,0.67,0.44,0.39,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">FIRST Study Group/MSBase</text>
   <text y="442.583" x="49.606" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="52.531,58.03,62.53,66.031,68.533,72.529,76.03,80.53,82.78,89.278,93.274,97.774,100.276,102.778,107.278,109.528,111.778,119.275,123.271,125.773,130.273,134.773,139.273,142.774,147.274,151.27,153.52,155.77,161.269,165.769,169.27,171.772,175.273,179.773,182.275,184.777,189.277,191.527" svgx:width="0.61,0.5,0.39,0.28,0.44,0.39,0.5,0.25,0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.83,0.44,0.28,0.5,0.5,0.5,0.39,0.5,0.44,0.25,0.25,0.61,0.5,0.39,0.28,0.39,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Eastern Health, Melbourne, Australia, </text>
   <text y="442.583" x="193.776" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="445.103" x="196.701,204.198,208.698,214.197,218.697,222.198,226.194,228.444,233.943,238.443,242.943,247.443,251.943,256.443,258.945,261.447,265.947,270.447" svgx:width="0.83,0.5,0.61,0.5,0.39,0.44,0.25,0.61,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MSBase Foundation </text>
   <text y="456.101" x="49.605,55.104,59.604,63.6,68.1,70.602,72.852,80.349,84.345,86.847,91.347,95.847,100.347,103.848,108.348,112.344,114.594,121.092,125.592,129.093,133.593,136.095,138.597,143.097,145.599,147.849,150.099,157.596,161.592,164.094,168.594,173.094,177.594,181.095,185.595,189.591,191.841,194.091,199.59,204.09,207.591,210.093,213.594,218.094,220.596,223.098,227.598,229.848" svgx:width="0.61,0.5,0.44,0.5,0.28,0.25,0.83,0.44,0.28,0.5,0.5,0.5,0.39,0.5,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.83,0.44,0.28,0.5,0.5,0.5,0.39,0.5,0.44,0.25,0.25,0.61,0.5,0.39,0.28,0.39,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Royal Melbourne Hospital, Melbourne, Australia, </text>
   <text y="453.583" x="232.098" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="456.103" x="235.023,239.019,243.519,248.019,252.519,254.769,261.267,265.767,270.267,272.769,276.765,280.266" svgx:width="0.44,0.5,0.5,0.5,0.25,0.72,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">John Hunter </text>
   <text y="467.101" x="49.605,56.103,60.603,64.104,68.604,71.106,73.608,78.108,80.61,82.86,85.11,91.113,95.109,101.112,105.108,109.608,113.109,115.611,118.113,122.109,124.359,126.609,132.108,136.608,140.109,142.611,146.112,150.612,153.114,155.616,160.116,162.366" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.67,0.44,0.67,0.44,0.5,0.39,0.28,0.28,0.44,0.25,0.25,0.61,0.5,0.39,0.28,0.39,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hospital, Newcastle, Australia, </text>
   <text y="464.583" x="164.616" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="467.103" x="167.541,173.04,177.54,181.536,186.036,188.538,190.788,198.285,202.281,204.783,209.283,213.783,218.283,221.784,226.284,230.28,232.53,239.028,243.528,247.029,251.529,254.031,256.533,261.033,263.535,265.785" svgx:width="0.61,0.5,0.44,0.5,0.28,0.25,0.83,0.44,0.28,0.5,0.5,0.5,0.39,0.5,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Royal Melbourne Hospital, </text>
   <text y="478.101" x="49.605,57.102,61.098,63.6,68.1,72.6,77.1,80.601,85.101,89.097,91.347,93.597,99.096,103.596,107.097,109.599,113.1,117.6,120.102,122.604,127.104,129.354" svgx:width="0.83,0.44,0.28,0.5,0.5,0.5,0.39,0.5,0.44,0.25,0.25,0.61,0.5,0.39,0.28,0.39,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Melbourne, Australia, </text>
   <text y="475.583" x="131.605" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="478.103" x="134.53,142.027,146.023,149.524,152.026,158.524,162.52,167.02,171.52,173.77,180.268,184.768,188.269,192.769,195.271,197.773,202.273,204.775,207.025,209.275,215.278,219.274,225.277,227.527,232.027,236.527,241.027,243.529,248.029,250.279,257.776,262.276,264.778,268.774,272.275,274.525" svgx:width="0.83,0.44,0.39,0.28,0.72,0.44,0.5,0.5,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.67,0.44,0.67,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.83,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Westmead Hospital, New South Wales, </text>
   <text y="489.101" x="49.606,55.105,59.605,63.106,65.608,69.109,73.609,76.111,78.613,83.113,85.363" svgx:width="0.61,0.5,0.39,0.28,0.39,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Australia, </text>
   <text y="486.583" x="87.613" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">6</text>
   <text y="489.103" x="90.538,96.037,98.539,101.041,104.542,108.538,113.038,115.288,121.786,125.782,130.282,132.784,135.286,139.786,142.036,144.286,151.783,155.779,158.281,162.781,167.281,171.781,175.282,179.782,183.778,186.028,188.278,193.777,198.277,201.778,204.28,207.781,212.281,214.783,217.285,221.785,224.035" svgx:width="0.61,0.28,0.28,0.39,0.44,0.5,0.25,0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.83,0.44,0.28,0.5,0.5,0.5,0.39,0.5,0.44,0.25,0.25,0.61,0.5,0.39,0.28,0.39,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Alfred Health, Melbourne, Australia, </text>
   <text y="486.583" x="226.284" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">7</text>
   <text y="489.103" x="229.209,234.708,239.208,242.709,245.211,249.207,252.708,257.208" svgx:width="0.61,0.5,0.39,0.28,0.44,0.39,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Eastern </text>
   <text y="500.101" x="49.605,56.103,60.099,64.599,67.101,69.603,74.103,76.353,78.603,84.102,88.602,92.598,94.848,101.346,103.848,106.35,108.852,111.102,113.352,118.851,123.351,126.852,129.354,132.855,137.355,139.857,142.359" svgx:width="0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.72,0.28,0.28,0.28,0.25,0.25,0.61,0.5,0.39,0.28,0.39,0.5,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Health, Box Hill, Australia</text>
   <text y="527.101" x="49.605,55.608,60.108,64.104,69.108,73.608,77.442,81.942,86.946,91.95,96.954,99.951" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="527.101" x="103.434,108.933,113.433,117.429,119.679,120.912,124.908,129.408,136.41,140.91,144.906,147.903,151.899,154.401,156.903,161.403,165.399,167.649,168.882,171.384,175.884,180.384,184.884,187.134,188.367,190.869,194.865,197.862,204.864,207.114,208.347,211.848,215.844,218.841,222.837,225.339,229.839,232.089,233.322,237.822,240.819,245.319,248.316,250.818,253.32,257.316,259.566,260.799,265.299,268.296,270.546,271.779,276.279,278.781,282.282" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.44,0.33,0.78,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The comparative long term safety profile of dis-</text>
   <text y="538.099" x="49.605,53.601,57.597,61.098,65.094,68.091,75.093,79.593,84.093,86.595,89.592,94.092,96.594,101.094,105.594,107.844,110.013,112.515,117.015,121.011,124.008,128.004,132.504,137.004,139.254,141.423,144.42,150.918,158.919,164.418,167.415,169.665,171.834,174.336,178.836,181.086,183.255,191.256,196.26,198.51,200.679,203.181,206.178,210.174,214.17,216.672,223.674,227.67,232.17,234.672,236.922,239.091,241.593,245.094,247.344,249.513,254.013,258.513,263.013,267.513,272.013,278.511,283.011,285.261" svgx:width="0.44,0.44,0.39,0.44,0.33,0.78,0.5,0.5,0.28,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.33,0.72,0.89,0.61,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.39,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.72,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ease-modifying therapy (DMT) in MS treatment is unknown. </text>
   <text y="549.097" x="49.605,56.103,58.605,61.107,65.607,70.107,74.607,79.107,83.607,86.073,90.069,94.569,99.069,103.065,106.062,109.563,113.559,116.025,120.021,124.521,128.517,133.017,135.519,139.02,141.486,144.987,149.487,153.483,157.983,160.449,164.445,167.946,170.412,172.914,177.414,180.411,184.407,188.403,190.905,193.407,197.907,202.407,204.873,207.87,210.372,213.873,218.373,220.839,224.835,229.335,233.835,236.301,238.803,241.305,245.805,249.801,252.798,255.264,258.261,262.761,267.261,271.257,273.759,276.261,280.761,285.261" svgx:width="0.72,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.28,0.39,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.28,0.5,0.44,0.33,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Although adverse events such as infection risk and liver function </text>
   <text y="560.095" x="49.605,52.107,56.103,59.604,62.106,64.356,65.868,68.865,74.364,79.368,84.867,87.864,90.114,91.626,95.622,100.122,104.622,109.122,112.119,119.121,123.117,125.619,128.121,130.623,133.125,137.121,140.622,142.872,144.384,148.38,151.377,155.373,157.623,159.135,163.635,168.135,172.635,179.133,183.633,185.883,187.395,191.895,196.395,199.896,203.397,205.899,210.399,212.901,216.897,219.147,220.659,224.16,226.662,231.162,235.158,237.408,238.92,242.916,245.751,248.748,252.744,256.74,259.242,262.743,264.993,267.243,268.755,271.257,275.757,279.753,282.255" svgx:width="0.28,0.44,0.39,0.28,0.25,0.55,0.33,0.61,0.56,0.61,0.33,0.25,0.55,0.44,0.5,0.5,0.5,0.33,0.78,0.44,0.28,0.28,0.28,0.28,0.44,0.39,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.5,0.72,0.5,0.25,0.55,0.5,0.5,0.39,0.39,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">test (LFT) abnormalities are known possible side effects, inci-</text>
   <text y="571.093" x="49.605,54.105,58.101,62.601,66.597,70.593,73.311,77.307,81.807,86.307,89.025,91.527,94.524,98.52,103.02,107.52,111.021,113.739,118.239,122.739,126.735,129.732,132.45,134.952,137.454,144.456,148.452,151.17,153.672,158.172,160.89,164.391,168.387,171.384,173.886,178.386,182.886,186.387,189.105,193.101,197.601,202.101,206.097,209.094,212.595,216.591,219.309,223.305,227.805,231.801,236.301,238.803,242.304,245.022,248.019,253.023,259.521,265.02,268.521,271.518,274.236,278.232,281.229,285.225" svgx:width="0.5,0.44,0.5,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.28,0.33,0.44,0.5,0.5,0.39,0.25,0.5,0.5,0.44,0.33,0.25,0.28,0.28,0.78,0.44,0.25,0.28,0.5,0.25,0.39,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.33,0.56,0.72,0.61,0.39,0.33,0.25,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dence and trends over time in serious adverse events (SAEs) are </text>
   <text y="582.091" x="49.605,52.107,56.103,59.604,63.105,65.481,71.979,75.975,78.477,80.979,83.355,87.351,91.851,95.847,98.844,102.84,106.836,109.338,113.334,116.331,118.833,122.334,126.33,130.83,133.206,135.708,140.208,142.584,145.581,149.577,153.573,156.075,158.451,164.949,169.449,172.446,174.948,179.448,181.824,185.82,188.322,190.824,195.324,197.826,201.822,205.818,208.32,210.696,215.196,218.193,222.189,226.185,228.687,231.189,235.185,239.181,241.431,243.807,251.808,256.812,259.188,264.192,267.189,273.192,278.196,283.029,285.279" svgx:width="0.28,0.44,0.39,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.33,0.44,0.44,0.28,0.25,0.72,0.5,0.33,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.44,0.44,0.25,0.25,0.89,0.56,0.25,0.56,0.33,0.67,0.56,0.61,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">less well characterised in real world clinical practice. MS FIRST, </text>
   <text y="593.089" x="49.605,53.601,56.157,59.658,64.158,68.658,71.655,75.156,77.658,82.158,86.658,91.158,93.714,98.214,101.211,103.767,106.269,110.769,114.765,117.321,125.322,130.326,136.329,140.325,143.826,147.822,150.378,153.375,157.371,161.871,164.373,167.874,170.376,173.373,177.288,179.538,182.094,184.596,188.097,190.653,194.649,199.149,201.21,207.708,212.208,215.709,218.211,221.208,225.204,227.706,230.208,234.204,238.704,241.26,248.262,252.762,255.264,257.766,260.268,263.265,267.261,271.257,275.757,278.259,281.256,285.252" svgx:width="0.44,0.25,0.39,0.5,0.5,0.33,0.39,0.28,0.5,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.67,0.44,0.39,0.44,0.25,0.33,0.44,0.5,0.28,0.39,0.28,0.33,0.5,0.25,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.72,0.5,0.39,0.28,0.33,0.44,0.28,0.28,0.44,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.33,0.44,0.44,0.5,0.28,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">a sub-study of the MSBase registry, is an Australian multi-centre </text>
   <text y="604.087" x="49.605,53.106,55.608,60.108,64.608,69.108,71.925,74.427,78.927,81.744,84.246,91.248,95.748,98.25,102.246,109.248,113.244,117.744,120.246,123.063,127.059,129.876,134.376,137.877,141.873,144.69,147.687,150.684,153.681,156.183,160.179,164.679,169.179,171.681,176.181,178.998,182.499,186.495,189.492,193.488,195.99,200.49,203.307,210.309,214.809,219.309,223.809,226.311,230.307,233.124,235.626,240.126,242.943,245.445,248.442,252.438,256.434,260.934,263.751,267.252,271.248,274.245,278.241,280.743,285.243" svgx:width="0.39,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.25,0.44,0.25,0.5,0.39,0.44,0.33,0.33,0.33,0.33,0.28,0.44,0.5,0.5,0.28,0.5,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.5,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">study to implement a user-friendly safety module to track safety </text>
   <text y="615.085" x="49.605,54.105,58.605,61.107,65.103,69.603,76.605,80.601,84.102,86.352,88.854,93.354,95.604,103.605,108.609,110.859,115.359,119.355,121.857,124.359,128.355,132.855,135.357,138.858,141.108,145.608,150.108,154.104,157.101,159.351,161.853,166.353,170.349,172.599,175.101,179.601,184.101,188.601,190.851,193.353,197.349,200.346,207.348" svgx:width="0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.5,0.25,0.28,0.44,0.33,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">outcomes in MS patients over the long term.</text>
   <text y="626.083" x="49.605,56.607,61.611,64.608,68.604,72.6,75.597,78.099,82.599,86.595,90.096,93.093" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="626.083" x="96.36,101.859,106.359,110.355,112.605,113.622,118.122,121.119,123.621,130.623,134.619,137.616,142.116,144.366,145.383,149.883,154.383,156.885,160.881,164.877,167.379,169.881,174.381,178.377,180.627,181.644,186.144,189.141,191.391,192.408,194.91,199.41,201.912,205.413,207.663,208.68,212.181,214.683,219.183,223.683,228.183,230.433,231.45,233.952,237.453,239.703,240.72,243.222,247.722,249.972,250.989,253.491,256.488,260.484,264.48,268.98,271.23,272.247,276.243,280.743,285.243" svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.55,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The primary objective of this study is to track and </text>
   <text y="637.081" x="49.605,53.601,58.101,65.103,69.603,73.599,76.596,80.592,82.842,84.165,86.667,91.167,95.163,97.413,98.736,101.238,105.738,109.734,112.236,116.736,120.732,125.232,129.228,133.224,135.474,136.797,141.297,144.294,146.544,147.867,151.368,155.364,158.361,162.357,164.859,169.359,171.609,172.932,177.432,181.932,184.434,188.43,192.93,199.932,203.928,207.429,209.679,211.002,213.504,218.004,220.254,221.577,229.578,234.582,236.832,238.155,242.655,246.651,249.153,251.655,255.651,260.151,262.653,266.154,268.404,269.727,276.225,280.725,285.225" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">compare the incidence of safety outcomes in MS patients who </text>
   <text y="648.079" x="49.605,53.601,56.103,58.605,63.105,67.101,70.098,72.438,75.435,79.431,83.427,87.423,89.925,94.425,98.421,100.761,107.259,115.26,120.597,122.937,125.934,128.436,132.936,136.932,139.434,143.934,148.434,150.936,155.436,159.936,162.276,165.273,167.775,172.275,176.775,181.275,183.777,186.279,193.281,197.781,202.281,204.621,208.617,212.613,216.609,221.109,224.106,228.606,231.108,235.608,240.108,242.448,244.95,249.45,251.79,255.786,260.286,264.786,267.783,272.283,276.783,280.779,285.279" svgx:width="0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.25,0.72,0.89,0.61,0.25,0.33,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">either receive DMT (including fingolimod according to approved </text>
   <text y="659.077" x="49.605,52.107,56.103,60.603,64.599,67.101,70.098,72.879,77.379,80.376,83.157,89.655,94.155,98.655,101.436,105.432,108.429,112.425,115.206,119.706,124.206,126.987,131.487,135.987,138.768,141.27,144.267,148.263,152.259,154.761,161.763,165.759,170.259,172.761,175.011,177.63,183.129,187.629,191.625,194.406,197.907,201.903,205.899,210.399,214.899,219.399,223.395,226.392,230.892,233.673,238.173,242.673,245.175,249.171,253.167,255.669,258.171,262.671,266.667,269.448,271.95,275.451,278.232,280.734,285.234" svgx:width="0.28,0.44,0.5,0.44,0.28,0.33,0.25,0.5,0.33,0.25,0.72,0.5,0.5,0.25,0.44,0.33,0.44,0.25,0.5,0.5,0.25,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.61,0.5,0.44,0.25,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.39,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">label) or who are on no treatment. The secondary objective is to </text>
   <text y="670.075" x="49.605,53.601,58.101,62.097,65.094,69.09,73.086,75.588,79.584,82.581,85.083,89.079,93.075,94.956,97.458,101.958,105.954,107.835,110.337,114.837,119.337,123.837,126.339,128.841,133.341,137.841,140.343,144.843,148.839,151.341,153.222,157.722,160.224,163.725,166.227,169.224,171.726,176.226,180.726,183.228,185.73,190.23,194.73,196.611,201.111,204.108,205.989,208.491,212.991,219.993,224.493,228.993,233.493,237.489,241.989,244.491,248.487,250.368,254.364,258.864,263.364,267.864,270.366,272.247,276.243,280.743,285.243" svgx:width="0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.25,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.44,0.5,0.5,0.5,0.28,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">characterize the longitudinal distribution of lymphocyte count and </text>
   <text y="681.073" x="49.605,55.104,60.108,65.445,67.695,71.691,76.191,80.691,85.191,88.188,95.19,99.186,101.688,104.19,106.692,109.194,113.19,116.691,118.941,121.443,125.943,128.193,131.19,133.692,138.192,142.692,147.192,149.694,152.196,159.198,163.698,168.198,170.448,172.95,175.947,179.943,183.939,186.441,190.437,194.937,197.187,201.687,205.683,208.185,210.687,214.683,219.183,221.685,225.186" svgx:width="0.61,0.56,0.61,0.25,0.44,0.5,0.5,0.5,0.33,0.78,0.44,0.28,0.28,0.28,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LFT abnormalities in fingolimod treated patients.</text>
   <text y="692.071" x="49.605,58.101,62.097,65.094,70.098,74.598,79.602,83.103,86.1" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="692.071" x="88.395,94.893,98.889,101.391,105.387,107.682,110.679,113.676,118.176,125.178,127.473,129.975,134.475,138.471,140.766,147.768,152.268,156.768,161.268,163.77,167.766,170.061,176.559,180.555,184.056,186.351,190.347,194.847,197.349,200.346,204.342,208.338,210.84,214.836,219.336,221.631,226.131,230.631,232.926,237.426,241.926,243.726,250.224,254.724,257.721,260.223,262.725,265.02,269.52,274.02,278.52,283.02,285.27" svgx:width="0.72,0.44,0.28,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.25,0.72,0.5,0.33,0.28,0.28,0.25,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Data from the module was extracted on 10 April 2014. </text>
   <text y="703.069" x="49.605,54.609,58.605,61.107,63.609,67.605,72.105,74.607,78.108,80.358,81.294,85.29,89.79,94.29,96.792,99.789,102.291,106.791,111.291,113.793,116.295,120.795,125.295,127.545,128.481,132.477,134.727,135.663,140.163,144.159,147.66,151.656,154.158,156.66,161.16,165.156,167.406,168.342,172.338,176.838,181.338,183.588,184.524,188.52,191.022,193.272,194.208,196.71,200.706,204.702,208.203,210.705,212.955,213.891,218.391,220.641,221.577,226.077,230.577,234.078,236.58,239.577,244.077,248.073,251.574,255.57,258.072,260.574,265.074,269.07,271.32,272.256,275.253,279.753,282.255" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.44,0.44,0.39,0.28,0.25,0.55,0.5,0.25,0.55,0.5,0.5,0.39,0.28,0.33,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients contributing a baseline and at least 1 post-baseline fol-</text>
   <text y="714.067" x="49.605,52.107,56.607,63.105,66.102,70.602,75.102,77.352,78.288,82.788,85.29,88.791,91.293,93.795,96.045,96.981,103.479,107.475,110.472,114.468,116.718,117.654,120.156,124.656,128.652,131.154,135.654,140.154,144.15,148.65,150.9,151.836,154.338,158.838,161.088,162.024,164.526,169.026,173.022,175.272,176.208,180.708,184.704,188.205,192.201,195.198,197.7,202.2,204.702,207.204,211.704,215.7,217.95,218.886,222.882,227.382,231.378,233.88,238.38,241.881,245.877,249.378,251.628,252.564,255.561,260.061,264.057,268.053,271.05,274.551,276.801,277.737,282.237,285.234" svgx:width="0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.28,0.28,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.39,0.25,0.55,0.33,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">low-up visit were included in the descriptive analyses (years of </text>
   <text y="725.065" x="49.605,52.602,57.102,59.604,62.106,66.606,73.104,76.101,80.601,85.101,87.603,89.853,92.85,95.847,99.843,104.343,108.843,112.839,117.339,121.335,125.835,128.085,132.585,135.582,137.832,141.828,146.328,150.324,154.824,157.326,159.576,163.572,168.072,172.572,177.072,179.574,183.075,186.072" svgx:width="0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.28,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.5,0.28,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">follow-up; frequency of event counts).</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 402.300 L345.990 402.300 "/>
  <g begin="text">
   <text y="77.103" x="297.26,303.893,308.024,311.66,316.799,319.436,322.568,326.204,329.336" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="77.103" x="333.125,339.758,343.394,345.644,347.183,351.314,353.951,356.201,357.74,360.377,365.012,369.143,371.393,372.932,377.567,381.698,384.335,388.466,390.716,392.255,396.89,400.022,402.272,403.811,408.446,412.577,415.214,419.345,421.595,423.134,427.265,431.9,439.037,443.672,446.309,448.946,453.077,455.714,458.351,462.986,467.621,470.006,472.256,473.795,481.931,487.07,489.32,490.859,495.998,499.13,505.268,510.407,515.879,518.129,519.668,524.303,528.434,532.934" svgx:width="0.72,0.39,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.89,0.56,0.25,0.55,0.56,0.33,0.67,0.56,0.61,0.25,0.55,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">As at the date of data compilation, MS FIRST had </text>
   <text y="88.101" x="297.26,301.391,306.026,309.158,313.793,316.43,319.067,323.198,327.833,330.083,332.207,336.842,341.477,346.112,350.747,352.997,355.121,359.756,363.887,366.524,369.161,373.292,377.927,380.564,384.2,386.45,388.574,391.706,396.341,400.976,405.611,410.246,412.496,414.62,418.751,421.388,424.025,428.66,431.297,435.428,437.678,439.802,444.437,447.074,450.71,453.347,455.984,459.62,462.005,464.255,466.379,470.51,475.145,482.282,486.917,489.554,493.685,496.322,498.959,503.594,507.725,509.975,512.099,516.734,521.369,526.004,528.389,532.889" svgx:width="0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.39,0.28,0.28,0.39,0.25,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">enrolled 1704 patients (3462 clinic visits, cumulative 802.7 </text>
   <text y="99.099" x="297.26,301.895,306.026,309.158,312.794,317.429,322.064,325.196,329.831,333.962,338.093,341.225,344.861,347.111,349.415,354.05,357.182,359.432,361.736,364.868,369.503,372.14,374.777,379.412,386.045,389.177,393.812,398.447,401.579,403.829,406.133,409.769,412.406,417.041,421.172,425.303,427.553,429.857,433.988,438.623,441.755,446.39,449.027,456.164,460.295,464.93,467.567,469.817,472.121,476.756,481.391,483.641,485.945,490.58,492.83,495.134,498.77,502.901,507.536,509.786,512.09,516.725,521.36,525.995,530.63,532.88" svgx:width="0.5,0.44,0.33,0.39,0.5,0.5,0.33,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.33,0.25,0.55,0.39,0.28,0.5,0.44,0.44,0.25,0.55,0.44,0.5,0.33,0.5,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">person-years of follow-up) since enrolment on 1 Jan 2012. </text>
   <text y="110.097" x="297.26,305.396,309.527,313.658,318.293,320.507,323.639,328.778,335.411,338.543,340.757,343.889,348.524,351.161,353.798,358.433,365.066,368.198,372.833,377.468,379.682,386.315,390.446,394.082,396.296,400.931,403.316,407.951,410.165,413.297,417.932,420.317,424.952,428.084,430.298,437.435,442.07,446.705,449.342,453.977,457.613,459.998,462.212,468.845,471.977,474.2,476.837,481.472,485.603,487.817,492.452,497.087,501.722,503.936,508.571,512.702,515.339,517.976,522.107,526.742,529.379,532.88" svgx:width="0.89,0.44,0.44,0.5,0.25,0.33,0.56,0.72,0.33,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.25,0.33,0.5,0.25,0.5,0.33,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.72,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Mean (SD) follow-up was 5.7 (6.7) months. Of the 904 patients </text>
   <text y="121.095" x="297.26,303.893,308.528,313.163,315.89,320.021,324.656,329.291,331.928,335.06,337.697,342.332,346.967,349.604,353.735,358.37,361.097,365.228,367.865,370.592,373.229,377.36,381.491,385.127,387.764,390.491,395.126,397.853,402.488,407.123,410.759,413.396,416.528,421.163,425.294,428.93,433.061,435.698,438.335,442.97,447.101,449.828,454.463,457.1,460.736,463.373,466.01,468.395,471.122,475.757,480.392,485.027,487.754,490.886,495.521,500.156,502.541,507.176,514.808,517.94,520.667,525.302,529.433,532.934" svgx:width="0.72,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.5,0.25,0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.25,0.5,0.5,0.39,0.28,0.33,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.28,0.39,0.28,0.28,0.25,0.25,0.5,0.5,0.5,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">who contributed at least 1 post-baseline visit, 703 (77.8%) has </text>
   <text y="132.093" x="297.26,301.895,306.026,310.157,314.792,317.177,321.308,325.943,330.578,335.213,338.849,342.98,347.615,350.0,352.637,357.272,359.657,366.29,374.426,379.898,382.283,386.918,391.553,394.685,397.322,401.957,406.592,408.977,412.109,416.744,419.381,422.018,426.653,433.286,436.418,441.053,445.688,448.073,450.458,457.091,460.223,462.608,465.245,469.88,474.011,477.647,481.778,484.163,486.548,491.183,495.818,500.453,502.838,505.97,510.605,515.24,517.625,522.26,529.892,532.889" svgx:width="0.5,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.89,0.61,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.25,0.72,0.33,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.25,0.5,0.5,0.5,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">been exposed to DMT during follow-up. Of these, 462 (65.7%) </text>
   <text y="143.091" x="297.26,301.895,306.026,310.661,312.911,313.73,317.861,322.496,327.131,331.766,335.402,340.037,343.169,347.3,349.55,350.369,353.006,357.641,359.891,360.71,363.842,366.479,371.114,375.749,380.384,383.021,385.658,392.795,397.43,402.065,404.45,407.024,413.657,417.788,420.92,425.555,429.191,432.827,435.077,435.896,438.533,443.168,447.299,449.549,450.368,455.003,459.638,463.274,467.405,470.537,475.172,479.303,481.94,484.577,489.212,493.847,496.097,496.916,501.551,505.682,508.814,511.451,516.086,520.721,522.971,523.79,528.425,532.925" svgx:width="0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.72,0.44,0.33,0.5,0.39,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">had exposure to fingolimod. Across the observation period 14 </text>
   <text y="154.089" x="297.26,299.897,304.532,307.664,311.795,315.926,318.563,321.2,325.835,329.966,332.216,335.726,340.865,347.498,353.132,356.768,359.153,361.403,364.913,369.548,374.183,376.433,379.943,386.576,390.707,393.839,398.474,402.605,406.241,408.491,412.001,417.635,422.27,425.906,428.543,432.674,435.806,438.056,441.566,445.697,450.332,454.463,459.098,461.735,465.371,467.756,470.006,473.516,478.151,480.401,483.911,491.048,495.179,497.816,500.453,505.088,509.723,513.854,518.489,522.62,525.257,529.388,532.889" svgx:width="0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.56,0.72,0.61,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.5,0.44,0.39,0.25,0.55,0.61,0.5,0.39,0.28,0.44,0.33,0.25,0.55,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.5,0.25,0.55,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">infective SAEs, 14 Herpes Zoster events, 2 malignancies </text>
   <text y="165.087" x="297.26,300.392,304.523,309.158,313.289,315.926,320.561,325.196,327.833,332.468,337.103,339.353,340.649,345.284,349.919,354.554,356.804,358.1,365.237,369.368,372.005,376.136,380.771,385.406,392.543,396.674,398.924,400.22,403.856,408.491,411.128,415.763,418.013,419.309,423.44,427.571,432.206,436.337,440.468,443.24,445.625,447.875,449.171,455.804,463.94,469.079,475.217,478.349,480.599,481.895,486.026,490.661,495.296,497.546,498.842,503.477,505.727,507.023,513.656,521.792,526.931,532.934" svgx:width="0.33,0.44,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.5,0.5,0.78,0.44,0.25,0.55,0.39,0.5,0.28,0.5,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.25,0.55,0.72,0.89,0.56,0.67,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.72,0.89,0.56,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(excluding non melanoma skin cancer, NMSC) and 5 NMSC </text>
   <text y="176.085" x="297.26,303.893,308.024,311.156,315.287,317.186,320.318,324.449,328.58,333.215,336.347,340.982,345.113,349.748,351.647,356.282,360.917,362.816,365.948,368.585,373.22,377.855,382.49,385.127,387.764,394.901,399.536,404.171,406.556,408.455,412.586,417.221,424.358,428.993,433.124,436.256,440.387,445.022,446.921,453.554,456.191,458.828,463.463,465.362,469.997,471.896,474.533,479.168,482.3,486.431,490.562,493.199,495.836,500.471,505.106,507.005,512.144,518.777,524.411,527.048,530.684,532.934" svgx:width="0.72,0.44,0.33,0.44,0.25,0.33,0.44,0.44,0.5,0.33,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.56,0.72,0.61,0.33,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were recorded on fingolimod, compared with 9 infection SAEâ€™s, </text>
   <text y="187.083" x="297.26,301.895,304.145,305.828,312.461,316.592,319.724,324.359,328.49,332.126,334.376,336.059,341.693,346.328,349.964,352.601,356.732,359.504,361.889,364.139,365.822,370.457,372.707,374.39,381.527,385.658,388.295,390.932,395.567,400.202,404.333,408.968,413.099,415.736,419.867,423.503,425.753,427.436,431.567,436.202,440.837,443.087,444.77,449.405,451.655,453.338,459.971,468.107,473.246,479.384,481.634,483.317,487.952,492.587,494.837,496.52,500.651,505.286,509.921,512.171,513.854,518.489,521.126,525.761,529.892,532.889" svgx:width="0.5,0.25,0.55,0.72,0.44,0.33,0.5,0.44,0.39,0.25,0.55,0.61,0.5,0.39,0.28,0.44,0.33,0.25,0.25,0.55,0.5,0.25,0.55,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.72,0.89,0.56,0.67,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">8 Herpes Zoster, 4 malignancies and 7 NMSC on any other </text>
   <text y="198.081" x="297.26,303.893,312.029,316.997,319.382,321.551,326.186,330.821,335.456,337.625,342.26,346.391,349.028,351.665,355.796,360.431,363.068,366.704,368.873,373.508,378.143,380.312,383.444,386.081,390.716,395.351,399.986,402.623,405.26,412.397,417.032,421.667,423.836,427.967,432.602,437.237,439.874,443.006,445.643,450.278,454.913,457.55,461.681,466.316,468.485,473.12,477.755,482.39,487.025,489.194,491.831,496.466,503.603,508.238,512.873,517.508,521.639,526.274,528.911,532.907" svgx:width="0.72,0.89,0.61,0.25,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DMT. 575 patients on fingolimod contributed 2300 lymphocyte </text>
   <text y="209.079" x="297.26,301.391,306.026,310.661,315.296,317.933,321.569,323.819,325.214,329.345,333.98,338.615,340.865,342.26,347.894,353.033,358.667,361.799,365.435,367.82,370.07,371.465,378.098,381.23,383.48,384.875,387.512,392.147,396.278,399.914,404.045,406.43,408.68,410.075,414.71,419.345,421.595,422.99,426.122,430.757,433.142,437.777,445.409,448.541,450.791,452.186,455.318,459.449,463.58,468.215,471.347,475.982,480.113,484.748,486.998,488.393,492.524,495.161,497.411,498.806,501.443,505.574,509.705,513.341,515.978,518.228,519.623,524.258,528.893,532.889" svgx:width="0.44,0.5,0.5,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.56,0.61,0.33,0.39,0.25,0.25,0.55,0.72,0.33,0.25,0.55,0.28,0.5,0.44,0.39,0.44,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.33,0.44,0.44,0.5,0.33,0.5,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.44,0.44,0.39,0.28,0.25,0.55,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">counts and LFTÂ´s. Of these, 21 (3.7%) recorded at least one </text>
   <text y="220.077" x="297.26,299.897,304.532,311.669,316.304,320.939,325.574,329.705,334.34,336.977,341.108,343.358,344.177,348.308,352.943,357.578,362.213,364.85,367.1,367.919,373.13,375.38,376.199,380.834,383.219,387.854,390.104,390.923,397.556,402.191,404.828,407.465,411.101,413.738,415.988,416.807,421.442,426.077,428.327,429.146,433.781,437.912,440.549,443.186,447.317,451.952,454.589,458.225,460.475,461.294,464.426,468.557,472.688,477.323,480.455,485.09,489.221,493.856,496.106,496.925,501.056,503.306,504.125,508.256,512.891,517.526,522.161,524.798,527.048,527.867,532.943" svgx:width="0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.72,0.5,0.28,0.28,0.39,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.44,0.5,0.33,0.5,0.44,0.5,0.25,0.55,0.44,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.25,0.55,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lymphocyte count &lt; 0.2 whilst no patients recorded a count &lt; </text>
   <text y="231.075" x="297.26,301.895,304.28,308.915,311.3,313.334,317.969,322.604,324.638,327.77,332.405,337.04,339.425,344.06,351.692,354.824,356.858,361.493,365.624,368.261,370.898,375.029,379.664,382.301,385.937,387.971,391.103,395.234,399.365,404.0,407.132,411.767,415.898,420.533,422.567,426.698,428.732,433.367,437.498,444.635,451.772,455.903,457.937,462.572,465.209,469.844,472.481,476.612,483.749,488.384,491.021,493.055,495.692,498.824,502.955,507.59,511.226,515.861,519.992,524.627,527.264,529.901" svgx:width="0.5,0.25,0.5,0.25,0.25,0.5,0.5,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.44,0.44,0.5,0.33,0.5,0.44,0.5,0.25,0.44,0.25,0.5,0.44,0.78,0.78,0.44,0.25,0.5,0.28,0.5,0.28,0.44,0.78,0.5,0.28,0.25,0.28,0.33,0.44,0.5,0.39,0.5,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">0.1. 74 (12.9%) patients recorded a gamma glutamyl transpepti-</text>
   <text y="242.073" x="297.26,301.895,306.026,309.662,313.793,316.124,319.256,325.889,332.522,338.156,341.288,343.619,346.256,350.387,355.022,359.153,361.79,364.121,369.332,371.663,376.298,380.933,383.264,385.901,390.536,394.667,396.998,401.633,406.268,410.903,415.034,418.166,420.497,423.134,425.771,432.908,435.545,438.182,440.513,445.148,448.28,450.611,455.246,459.881,463.013,470.15,474.281,476.918,479.249,482.381,489.014,494.648,501.281,504.413,506.744,510.875,513.512,515.843,518.48,522.611,526.742,530.378,532.88" svgx:width="0.5,0.44,0.39,0.44,0.25,0.33,0.72,0.72,0.61,0.33,0.25,0.28,0.44,0.5,0.44,0.28,0.25,0.56,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.28,0.28,0.78,0.28,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.33,0.72,0.61,0.72,0.33,0.25,0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dase (GGT) level &gt; x5 the upper limit of normal (ULN) at least </text>
   <text y="253.071" x="297.26,301.895,306.53,310.661,314.792,317.177,321.812,326.447,328.832,331.964,334.601,339.236,343.871,348.506,351.143,353.78,360.917,365.552,370.187" svgx:width="0.5,0.5,0.44,0.44,0.25,0.5,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">once on fingolimod.</text>
   <text y="264.069" x="297.26,301.76,303.812,306.809,311.309,313.559,318.059,325.556,328.553,330.605,333.602,337.598,341.594,346.094,349.091,353.591,357.587,362.087,364.139,368.135,372.635,374.687,378.683,381.185,385.181,389.681,392.183,396.683,400.679,402.731,405.233,408.23,412.226,416.726,420.227,424.223,431.225,433.727,438.227,442.223,445.724,449.72,451.772,454.769,461.267,465.938,471.437,474.434,476.486,478.988,482.984,487.484,491.48,493.982,496.034,501.11,505.61,510.11,512.162,518.66,524.159,530.657" svgx:width="0.5,0.25,0.33,0.5,0.25,0.5,0.83,0.33,0.25,0.33,0.44,0.44,0.5,0.33,0.5,0.44,0.5,0.25,0.44,0.5,0.25,0.44,0.28,0.44,0.5,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.5,0.39,0.44,0.78,0.28,0.5,0.44,0.39,0.44,0.25,0.33,0.72,0.61,0.61,0.33,0.25,0.28,0.44,0.5,0.44,0.28,0.25,0.56,0.5,0.5,0.25,0.72,0.61,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">7 (1.2%) recorded an alanine transaminase (ALT) level &gt;5x ULN.</text>
   <text y="275.067" x="297.26,303.758,308.258,313.262,317.258,319.76,324.764,328.265,330.767,335.267,340.271,343.772,346.769" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="275.067" x="350.711,356.21,360.71,364.706,366.956,368.648,372.644,376.145,378.647,382.643,387.143,389.645,392.147,395.648,400.148,407.15,411.146,415.646,418.148,420.398,422.09,426.59,429.587,431.837,433.529,437.525,439.775,441.467,443.969,447.965,450.8,455.3,459.296,461.546,463.796,465.488,469.988,472.985,477.485,480.986,485.486,489.482,493.478,495.98,498.482,502.982,506.978,509.228,510.92,517.922,522.422,524.924,527.426,529.928" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.39,0.28,0.44,0.5,0.28,0.28,0.39,0.5,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.25,0.25,0.55,0.5,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The establishment of a large, prospective multi-</text>
   <text y="286.065" x="297.26,301.76,304.757,309.257,313.757,315.881,319.382,323.378,326.375,330.371,332.873,337.373,339.497,346.499,350.999,355.499,359.999,362.501,366.497,368.621,371.618,376.118,379.115,381.239,385.739,389.24,393.236,395.36,397.862,402.362,404.486,407.483,411.983,416.483,418.985,421.487,425.987,429.983,432.107,436.607,439.604,443.6,447.596,450.098,452.6,456.596,460.592,462.716,467.216,471.212,474.713,476.837,481.337,485.333,489.329,493.829,495.953,499.454,503.954,507.95,511.946,515.942,519.443,522.944,525.941,530.441,532.943" svgx:width="0.5,0.33,0.5,0.5,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.33,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.44,0.44,0.25,0.5,0.44,0.39,0.25,0.5,0.44,0.44,0.5,0.25,0.39,0.5,0.44,0.44,0.44,0.39,0.39,0.33,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">drug safety module for use in routine practice has been successful </text>
   <text y="297.063" x="297.26,299.762,304.262,306.512,307.349,311.849,315.845,318.347,322.343,324.593,325.43,327.932,332.432,335.024,341.522,346.022,349.523,352.025,355.022,359.018,361.52,364.022,368.018,370.268,372.518,373.355,376.352,378.854,381.104,381.941,385.937,390.437,394.937,397.439,401.939,404.189,405.026,409.526,412.523,417.023,421.523,424.025,428.525,432.521,434.771,435.608,438.11,445.112,449.612,454.112,457.109,459.611,463.607,468.107,470.609,472.859,473.696,476.198,480.698,484.199,486.701,491.201,495.701,498.203,501.704,503.954,504.791,507.293,511.793,514.295,518.795,521.045,521.882,524.384,528.884,532.88" svgx:width="0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.72,0.5,0.39,0.28,0.33,0.44,0.28,0.28,0.44,0.25,0.25,0.55,0.33,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.39,0.28,0.5,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to date in Australia. It could provide important insights into the </text>
   <text y="308.061" x="297.26,299.762,304.262,308.258,310.76,315.26,319.256,323.756,327.752,331.748,333.998,335.069,339.065,343.565,348.065,350.315,351.386,353.888,356.39,363.392,365.894,370.394,374.894,377.144,378.215,382.715,385.712,387.962,389.033,391.535,394.532,398.528,402.524,405.026,412.028,416.024,420.524,423.026,426.023,430.019,433.52,437.021,441.521,445.517,448.019,452.015,454.517,458.513,463.013,465.263,466.334,471.338,477.836,483.335,486.332,489.833,492.083,494.333,495.404,503.405,507.905,512.405,516.401,518.903,521.405,523.907,528.407,532.907" svgx:width="0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.28,0.78,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.56,0.72,0.61,0.33,0.39,0.25,0.25,0.55,0.89,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">incidence and timing of treatment-associated SAEÂ´s. Modelling </text>
   <text y="319.059" x="297.26,299.762,302.759,306.755,311.255,315.755,319.256,322.154,326.15,330.65,335.15,338.048,342.548,346.544,349.046,353.042,357.038,359.54,362.042,366.542,371.042,373.94,377.441,379.943,384.443,388.943,392.939,395.441,398.942,401.84,404.342,408.842,411.74,415.736,419.237,422.738,427.238,431.234,433.736,437.732,440.234,444.23,448.73,451.628,456.128,460.124,462.626,467.126,471.626,474.128,478.628,483.128,487.628,490.526,494.522,499.022,503.522,506.024,510.524,513.422,517.418,520.919,524.42,526.922,530.423,532.925" svgx:width="0.28,0.33,0.44,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.39,0.25,0.28,0.5,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.44,0.39,0.39,0.28,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">trends and detecting signals in associated pathology could assist </text>
   <text y="330.057" x="297.26,301.256,303.758,306.26,310.76,313.262,317.258,319.76,323.756,328.256,331.757,334.007,336.509,341.009,343.259,345.761,350.261,354.257,358.757,361.259,363.761,366.758,371.258,373.76,378.26,382.76,385.01,389.51,393.506,396.008,398.51,402.506,407.006,409.508,413.009,415.259,419.255,421.757,424.007,427.004,429.506,433.007,437.507" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.28,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.28,0.25,0.33,0.28,0.39,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinicians in identifying patients at risk.</text>
   <text y="357.057" x="297.26,302.759,307.259,311.759" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P861</text>
   <text y="368.055" x="297.26,303.263,307.763,312.767,317.267,319.769,322.766,327.77,332.774,335.276,340.28,344.78,347.282,349.532,353.033,357.029,361.025,366.029,373.526,375.776,380.276,386.774,393.272,395.522,398.024,403.028,408.032,412.028,416.528,420.524,424.025,426.275,428.777,433.781,436.031,444.527,449.531,451.781,456.785,461.285,464.282,466.784,470.78,475.784,478.781,482.282" svgx:width="0.67,0.5,0.56,0.5,0.28,0.33,0.56,0.56,0.28,0.56,0.5,0.28,0.25,0.39,0.44,0.44,0.56,0.83,0.25,0.5,0.72,0.72,0.25,0.28,0.56,0.56,0.44,0.5,0.44,0.39,0.25,0.28,0.56,0.25,0.94,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Longitudinal serum JCV indexes in MS patients </text>
   <text y="379.053" x="297.26,303.758,306.26,309.257,314.261,316.511,321.515,326.015,329.012,333.512,336.014,338.516,342.512,347.516,355.013,359.513,364.517,367.514,372.014,375.515,379.016,383.516,387.512,390.014,394.514,397.511,401.507,406.511,408.761,413.765,417.761,422.261,426.761,430.757,434.753,438.254,441.755,444.257,448.757,452.753,455.003,462.5,467.504,470.006,473.003,475.505,478.502,483.002,486.998,491.498,494.0" svgx:width="0.72,0.28,0.33,0.56,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.33,0.5,0.39,0.39,0.5,0.44,0.28,0.5,0.33,0.44,0.56,0.25,0.56,0.44,0.5,0.5,0.44,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.83,0.56,0.28,0.33,0.28,0.33,0.5,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">with natalizumab-associated progressive multifocal </text>
   <text y="390.051" x="297.26,299.762,303.758,308.762,313.766,318.266,322.262,327.266,331.262,335.258,340.262,345.266,349.766,352.268,356.768,361.772,366.272,369.269,374.273" svgx:width="0.28,0.44,0.56,0.56,0.5,0.44,0.56,0.44,0.44,0.56,0.56,0.5,0.28,0.5,0.56,0.5,0.33,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">leukoencephalopathy</text>
   <text y="401.049" x="297.26,303.758,306.008,312.506,316.502,321.002,325.502,329.498,333.998,338.498,342.998" svgx:width="0.72,0.25,0.72,0.44,0.5,0.5,0.44,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A Vennegoor</text>
   <text y="398.583" x="345.994" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="348.919,351.169,353.419,356.92,363.418,365.668,370.168,374.164,378.664,380.914,386.917,391.417,394.918,398.419,402.919" svgx:width="0.25,0.25,0.39,0.72,0.25,0.5,0.44,0.5,0.25,0.67,0.5,0.39,0.39,0.5,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JA van Rossum</text>
   <text y="398.583" x="409.921" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="412.846,415.096,417.346,425.347,427.597,436.093,440.089,442.591,445.093,447.595,451.591" svgx:width="0.25,0.25,0.89,0.25,0.94,0.44,0.28,0.28,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Wattjes</text>
   <text y="398.583" x="455.091" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="401.103" x="458.016,460.266,462.516,466.017,468.267,474.765,477.267,479.769,482.271,486.267,489.768,492.27,496.266,498.768" svgx:width="0.25,0.25,0.39,0.25,0.72,0.28,0.28,0.28,0.44,0.39,0.28,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Killestein</text>
   <text y="398.583" x="503.268" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="409.581" x="297.26" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="412.103" x="300.185,305.684,312.182,314.432,321.929,325.925,330.425,332.927,336.923,341.423,343.925,346.175,352.178,356.174,360.674,363.176,367.172,370.673,372.923,375.173,380.672,387.17,390.671,393.173,397.169,400.67,405.17,409.67,416.168,418.418,420.668,426.671,430.667,433.169,437.669,441.665,445.166,447.668,452.168,456.668,461.168" svgx:width="0.61,0.72,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.72,0.39,0.28,0.44,0.39,0.5,0.5,0.72,0.25,0.25,0.67,0.44,0.28,0.5,0.44,0.39,0.28,0.5,0.5,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">VU Medical Center, Amsterdam, Netherlands</text>
   <text y="439.103" x="297.26,303.263,307.763,311.759,316.763,321.263,325.097,329.597,334.601,339.605,344.609,347.606" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="439.103" x="351.539,357.038,361.538,365.534,367.784,369.467,373.967,376.964,380.96,384.461,388.457,392.957,396.953,400.949,403.199,404.882,409.382,412.379,414.629,416.312,419.813,424.313,428.813,433.313,435.563,437.246,443.249,447.749,452.249,456.749,459.251,463.751,468.251,472.751,476.747,483.749,485.999,487.52,493.478,495.98,498.977,503.477,506.978,509.228,510.911,513.908,517.409,523.412,529.91,532.907" svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.5,0.5,0.5,0.25,0.55,0.67,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.44,0.78,0.25,0.55,0.72,0.28,0.33,0.5,0.39,0.25,0.55,0.33,0.39,0.67,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The presence of John Cunningham Virus (JCV) </text>
   <text y="450.101" x="297.26,300.761,304.757,307.754,312.254,319.256,321.929,325.925,330.425,332.927,335.429,339.929,344.429,348.929,351.431,355.427,358.928,361.601,364.103,367.604,370.277,374.273,376.946,379.943,382.445,385.946,390.446,393.119,396.116,400.112,404.108,406.61,411.11,414.107,416.78,419.777,424.277,427.274,429.947,432.449,436.949,440.945,443.618,448.118,452.114,456.614,460.61,463.112,467.612,472.112,479.114,483.11,487.61,490.112,492.785,497.285,500.282,502.955,507.455,510.452,514.952,519.452,522.449,526.445,529.946" svgx:width="0.39,0.44,0.33,0.5,0.78,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.28,0.39,0.25,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">serum antibodies is a risk factor for the development of progres-</text>
   <text y="461.099" x="297.26,300.761,303.263,307.763,311.759,314.288,321.29,325.79,328.292,330.794,333.296,336.293,340.793,344.789,348.785,351.287,353.816,356.318,360.314,364.814,369.314,373.814,377.81,382.31,386.306,390.302,394.802,399.302,403.298,405.8,410.3,414.8,418.796,421.298,425.798,430.298,432.827,435.824,440.828,448.829,454.328,457.325,459.854,462.356,466.856,469.385,476.387,480.887,483.389,485.891,488.393,492.893,495.395,499.391,501.92,505.421,509.417,511.919,515.915,518.912,523.412,526.913,529.415,532.916" svgx:width="0.39,0.28,0.5,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.33,0.56,0.89,0.61,0.33,0.25,0.28,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sive multifocal leukoencephalopathy (PML) in multiple sclerosis </text>
   <text y="472.097" x="297.26,300.257,308.258,313.262,316.259,318.509,321.092,325.592,329.588,332.09,334.592,338.588,343.088,345.59,349.091,351.341,353.924,356.426,359.423,363.419,367.415,369.917,373.913,378.413,380.663,383.246,389.744,392.246,394.748,399.248,401.498,404.081,408.581,412.577,415.079,419.075,421.577,424.079,428.075,432.575,439.577,443.573,448.073,450.323,452.573,454.994,462.77,466.766,469.016,471.599,476.099,480.599,485.099,489.599,492.101,496.601,500.597,504.098,506.6,510.596,514.592,516.842,519.425,521.927,526.427,530.423,532.925" svgx:width="0.33,0.89,0.56,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.94,0.44,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.44,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(MS) patients treated with natalizumab. We hypothesize that </text>
   <text y="483.095" x="297.26,301.76,304.262,308.762,313.262,317.258,320.255,322.64,326.636,331.136,333.638,336.14,339.137,342.638,348.641,354.977,357.362,361.358,365.858,368.36,370.862,375.362,379.862,384.362,388.862,391.247,393.749,398.249,402.749,406.745,411.245,415.241,418.742,421.127,424.124,428.12,431.621,436.121,438.623,441.125,443.51,446.012,450.512,452.897,456.893,459.278,463.778,466.28,470.78,475.28,479.276,482.273,484.658,487.655,490.157,493.658,498.158,500.543,505.043,508.04,510.425,514.925,518.921,523.421,527.417,529.919" svgx:width="0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.25,0.28,0.5,0.25,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">higher anti-JCV antibody indexes result in a higher risk of devel-</text>
   <text y="494.093" x="297.26,301.76,306.26,308.762,313.262,317.762,320.012,325.016,333.017,338.516" svgx:width="0.5,0.5,0.28,0.5,0.5,0.25,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">oping PML.</text>
   <text y="505.091" x="297.26,304.352,309.446,312.533,316.619,320.705,323.792,326.384,330.974,335.06,338.651,341.738" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="505.091" x="347.498,352.457,357.047,359.297,362.807,366.893,371.483,375.569,378.161,382.751,386.837,389.429,393.515,395.765,399.275,403.865,406.952,411.038,414.125,419.219,427.31,432.566,434.816,438.326,440.918,445.508,450.098,454.688,457.28,459.872,464.462,469.052,471.644,476.234,480.32,482.912,485.162,488.672,492.263,496.349,499.436,504.026,511.118,513.3679999999999,516.878,520.469,526.562,532.898" svgx:width="0.61,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.5,0.33,0.44,0.33,0.56,0.89,0.61,0.25,0.55,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.25,0.55,0.39,0.44,0.33,0.5,0.78,0.25,0.55,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To evaluate pre-PML longitudinal serum JCV </text>
   <text y="516.089" x="297.26,299.852,304.442,309.032,313.118,317.708,321.794,325.385,327.662,330.254,334.844,337.121,340.208,344.798,349.388,352.475,354.752,362.843,367.937,370.214,374.804,378.89,381.482,384.074,388.16,392.75,395.342,398.933,401.21,407.798,412.388,416.978,419.255,423.845,427.931,432.521,436.607,439.199,443.789,448.379,452.465,457.055,459.332,463.922,468.008,470.6,474.686,477.278,479.87,483.956,488.546,495.638,499.724,504.314,507.401,511.487,515.078,518.669,523.259,527.345,529.937" svgx:width="0.28,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.33,0.5,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">indexes in four MS patients who developed natalizumab-associ-</text>
   <text y="527.087" x="297.26,301.346,303.938,308.024,312.614,314.954,320.048,328.139,333.728" svgx:width="0.44,0.28,0.44,0.5,0.25,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ated PML.</text>
   <text y="538.085" x="297.26,305.756,309.752,312.749,317.753,322.253,327.257,330.758,333.755" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="538.085" x="335.744,343.52,347.516,349.505,356.507,360.503,364.499,368.0,372.5,375.497,379.493,383.993,385.982,390.482,393.479,400.481,404.981,409.481,411.983,416.483,418.985,423.485,425.465,427.967,432.467,436.967,441.467,443.969,446.471,450.971,455.471,457.973,462.473,466.469,468.971,470.96,474.461,478.457,481.454,485.954,492.956,494.936,498.437,502.433,509.435,513.935,516.437,520.433,523.934,525.923,528.425,532.925" svgx:width="0.94,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.25,0.39,0.44,0.33,0.5,0.78,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We measured 3-monthly longitudinal serum samples in </text>
   <text y="549.083" x="297.26,300.257,304.757,309.257,312.254,315.071,323.072,328.076,330.893,335.393,339.389,341.891,344.393,348.389,352.889,355.391,358.892,361.709,368.207,372.707,377.207,380.024,384.524,388.52,393.02,397.016,399.518,404.018,408.518,412.514,417.014,419.831,424.835,432.836,438.002,440.819,445.319,449.819,452.816,455.318,459.818,464.318,467.135,471.635,475.631,478.133,482.129,484.631,487.133,491.129,495.629,502.631,506.627,511.127,513.944,516.446,519.443,523.439,527.435,529.937" svgx:width="0.33,0.5,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.56,0.89,0.61,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">four MS patients who developed PML during natalizumab treat-</text>
   <text y="560.081" x="297.26,304.262,308.258,312.758,315.26,317.51,318.365,320.867,325.367,327.617,328.472,330.974,335.474,339.47,341.72,342.575,350.576,355.58,357.83,358.685,364.688,368.684,373.184,375.686,379.682,382.679,385.289,391.787,398.789,402.29,404.792,408.788,411.785,416.285,420.281,427.283,429.533,431.783,432.476,437.975,442.475,446.471,448.721,449.576,456.074,460.07,462.572,467.072,471.068,474.065,476.567,480.563,485.063,489.563,493.064,495.314,497.564,498.419,503.423,507.419,514.421,518.921,521.423,523.925,528.425,532.925" svgx:width="0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.25,0.55,0.67,0.44,0.5,0.28,0.44,0.33,0.25,0.72,0.78,0.39,0.28,0.44,0.33,0.5,0.44,0.78,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.72,0.44,0.28,0.5,0.44,0.33,0.28,0.44,0.5,0.5,0.39,0.25,0.25,0.55,0.56,0.44,0.78,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment in the MS Center Amsterdam, The Netherlands. Sampling </text>
   <text y="571.079" x="297.26,299.762,304.262,308.762,313.262,315.512,316.349,320.849,323.351,327.347,331.343,335.339,337.589,338.426,341.423,344.42,348.92,355.922,358.172,359.009,363.509,367.505,370.502,375.002,377.999,381.995,384.245,385.082,389.582,393.578,396.08,400.076,402.578,405.08,409.076,413.576,420.578,424.574,429.074,431.324,432.161,434.663,439.163,441.665,444.167,446.669,450.665,453.167,455.669,460.169,464.669,466.919,467.756,472.256,476.756,479.258,481.76,484.262,486.512,487.349,489.851,494.351,498.347,500.597,501.434,505.934,509.93,514.43,518.426,520.928,525.428,529.928" svgx:width="0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.28,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">took place from before natalizumab initiation until the develop-</text>
   <text y="582.077" x="297.26,304.262,308.258,312.758,315.26,317.483,321.983,324.98,327.203,332.207,340.208,345.707,347.957,350.18,353.177,357.677,362.177,366.173,370.673,374.669,378.17,380.393,386.891,390.887,393.884,397.88,400.103,404.099,408.599,415.601,420.101,424.097,427.094,431.09,435.59,437.813,440.315,444.815,447.038,449.54,454.04,458.54,462.041,466.037,468.26,471.257,474.254,478.754,485.756,487.979,491.975,494.477,496.979,499.202,503.702,506.204,510.704,514.7,517.697,519.92,527.921,532.925" svgx:width="0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.56,0.89,0.61,0.25,0.25,0.33,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.39,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.44,0.28,0.28,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment of PML. Indexes were compared to those from all other MS </text>
   <text y="593.075" x="297.26,301.76,305.756,308.258,310.76,314.756,319.256,321.758,325.259,327.509,328.589,331.091,334.088,338.084,342.08,344.582,348.578,353.078,355.328,356.408,362.906,365.408,367.91,372.41,374.66,375.74,380.24,384.236,386.738,390.734,393.236,395.738,399.734,404.234,411.236,415.232,419.732,421.982,423.062,425.564,430.064,432.314,433.394,435.896,440.396,444.392,446.642,447.722,455.723,460.727,462.977,464.057,470.06,474.056,478.556,481.058,485.054,488.051,490.886,497.384,504.386,507.887,510.389,514.385,517.382,521.882,525.878,532.88" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.25,0.55,0.67,0.44,0.5,0.28,0.44,0.33,0.25,0.72,0.78,0.39,0.28,0.44,0.33,0.5,0.44,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients treated with natalizumab in the MS Center Amsterdam </text>
   <text y="604.073" x="297.26,300.257,304.757,309.833,314.333,318.833,323.333,326.33,328.58,330.83,335.276,341.774,346.274,348.776,351.278,354.275,356.525,361.466,364.967,371.465,377.468,379.718,384.659,388.655,393.155,395.657,398.159,402.659,407.159,411.659,414.161,418.157,421.658,423.908,428.849,435.347,439.343,442.34,446.336,448.586,453.527,460.529,464.525,468.521,472.022,476.522,479.519,483.515,488.015,490.265,495.206,499.706,503.207,505.709,510.209,514.709,516.959,521.9,524.402,528.902,532.898" svgx:width="0.33,0.5,0.56,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.33,0.25,0.55,0.39,0.72,0.67,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(n=140). Anti- JVC antibodies were measured using the </text>
   <text y="615.071" x="297.26,302.264,307.763,313.766,319.265,324.764,327.761,332.765,338.93,341.18,343.682,347.678,351.179,353.681" svgx:width="0.56,0.61,0.67,0.72,0.61,0.33,0.56,0.72,0.25,0.28,0.44,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">STRATIFY test.</text>
   <text y="626.069" x="297.26,303.758,307.754,311.255,316.259,318.761,321.758,325.259,328.256" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="626.069" x="332.18,338.678,341.18,343.682,345.932,347.606,350.603,355.103,359.603,362.6,364.85,366.524,371.024,375.02,377.522,380.024,384.02,388.52,391.022,394.523,396.773,398.447,401.948,406.448,410.948,417.446,419.696,421.37,424.367,428.363,430.865,435.365,439.361,442.358,444.608,446.282,449.783,452.285,456.281,460.781,463.283,467.279,469.529,471.203,475.703,478.205,482.705,487.205,489.455,491.129,494.63,498.626,501.623,506.123,513.125,515.375,517.049,520.55,526.553,532.889" svgx:width="0.72,0.28,0.28,0.25,0.55,0.33,0.5,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.72,0.25,0.55,0.33,0.44,0.28,0.5,0.44,0.33,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.78,0.25,0.55,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">All four patients show rather stable high serum JCV </text>
   <text y="637.067" x="297.26,299.762,304.262,308.762,312.758,317.258,321.254,324.755,327.005,327.68,332.18,336.176,339.173,343.673,346.67,350.666,352.916,353.591,358.091,362.087,366.587,370.583,373.085,377.585,382.085,384.587,389.087,393.587,395.837,396.512,401.516,409.517,415.016,417.266,420.191,426.194,430.694,437.696,442.196,446.192,449.189,453.185,457.685,459.935,460.61,463.112,467.612,470.537,474.533,477.035,479.537,481.787,482.462,486.962,490.958,493.46,495.962,499.958,504.458,506.96,510.461,513.386,517.886,521.387,523.889,528.389,532.889" svgx:width="0.28,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.56,0.89,0.61,0.25,0.25,0.67,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">indexes before developing PML. Compared to all patients using </text>
   <text y="648.065" x="297.26,301.76,305.756,308.258,312.254,314.756,317.258,321.254,325.754,332.756,336.752,341.252,343.502,345.752,346.706,351.206,355.202,357.704,360.206,364.202,368.702,371.204,374.705,376.955,377.909,384.407,388.907,393.407,395.657,396.611,401.111,405.107,409.607,413.603,416.105,420.605,425.105,429.101,433.601,435.851,436.805,441.809,449.81,454.976,457.226,458.18,462.68,466.676,471.176,473.426,474.38,478.88,481.382,485.882,490.382,494.378,497.375,499.625,500.579,504.575,509.075,511.577,514.079,517.076,520.577,526.58,532.916" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab, patients who developed PML had higher anti-JCV </text>
   <text y="659.063" x="297.26,304.262,308.258,312.254,316.754,319.004,319.769,323.765,328.265,330.767,333.269,337.769,342.269,346.769,351.269,353.519,354.284,356.786,361.286,365.786,369.782,374.282,378.278,381.779,384.029,386.279,387.035,393.533,398.033,400.283,401.048,403.55,408.05,412.046,415.043,419.039,423.035,426.536,430.532,432.782,433.547,438.047,441.044,443.294,444.059,446.561,451.061,455.057,457.307,458.072,461.573,467.576,473.912,476.162,476.927,479.429,483.929,488.429,492.425,496.925,499.175,499.931,506.429,510.425,513.926,516.176,516.941,520.442,524.438,528.434,532.934" svgx:width="0.78,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.25,0.55,0.72,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mean antibody indexes. No increase of the JCV index was seen </text>
   <text y="670.061" x="297.26,301.76,305.756,308.753,313.253,316.25,320.246,322.496,324.998,329.498,333.494,335.744,340.244,342.746,346.742,351.242,355.742,360.242,363.743,366.245,369.746,371.996,377.0,385.001,390.5" svgx:width="0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">before the diagnosis PML.</text>
   <text y="681.059" x="297.26,303.758,308.258,313.262,317.258,319.76,324.764,328.265,330.767,335.267,340.271,343.772,346.769" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="681.059" x="349.991,356.489,358.991,363.491,367.991,371.987,374.984,377.234,378.206,382.202,386.702,389.204,391.706,394.703,398.204,404.207,410.543,412.793,413.765,417.761,422.261,424.763,427.265,431.765,436.265,440.765,445.265,447.515,448.487,450.989,455.489,459.989,463.985,468.485,472.481,475.982,478.232,479.204,486.206,488.708,493.208,497.708,500.21,502.46,503.432,505.934,510.434,514.43,517.427,521.423,525.419,528.92,532.916" svgx:width="0.72,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.78,0.28,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Higher anti-JCV antibody indexes might increase </text>
   <text y="692.057" x="297.26,299.762,304.262,308.258,310.652,313.649,316.151,319.652,324.152,326.537,331.037,334.034,336.428,341.432,349.433,354.599,356.993,363.491,365.993,368.495,372.995,375.497,379.997,382.391,384.893,389.393,393.389,395.774,399.275,405.278,411.614,414.008,418.508,423.008,426.509,429.011,431.513,434.015,438.515,442.511,444.905,449.405,453.401,455.903,458.405,462.401,466.901,469.403,472.904,475.289,479.789,484.289,486.683,491.183,495.179,497.681,501.677,504.179,506.681,510.677,515.177,522.179,526.175,530.675,532.925" svgx:width="0.28,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.56,0.89,0.61,0.25,0.72,0.28,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.67,0.72,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the risk of PML within the JCV positive patients on natalizumab. </text>
   <text y="703.055" x="297.26,305.756,310.256,314.252,316.754,321.254,325.25,328.247,330.497,331.334,333.836,338.336,342.332,344.582,345.419,349.919,353.915,356.417,360.917,365.417,367.919,370.169,371.006,375.506,378.503,380.753,381.59,384.092,388.592,392.588,394.838,395.675,399.671,404.171,406.673,409.175,412.172,415.673,421.676,428.012,430.262,431.099,435.095,439.595,442.097,444.599,449.099,453.599,458.099,462.599,464.849,465.686,468.188,472.688,477.188,481.184,485.684,487.934,488.771,491.273,494.774,497.024,497.861,501.857,504.107,504.944,508.445,512.945,516.941,520.937,523.439,526.436,528.938,532.934" svgx:width="0.94,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Whether the height of the anti-JCV antibody index is a specific </text>
   <text y="714.053" x="297.26,300.257,302.759,306.26,310.76,312.758,315.755,319.751,323.747,326.249,330.749,333.746,335.744,338.246,342.746,346.742,349.244,351.242,358.244,362.24,366.74,368.738,373.238,377.234,379.232,382.733,386.729,389.726,393.722,396.224,400.724,402.722,406.718,411.218,415.718,418.22,420.722,424.718,429.218,431.216,433.718,438.218,440.216,444.716,448.712,451.214,453.716,458.216,460.214,464.714,467.711,471.707,475.703,478.205,480.707,484.703,488.699,490.949,492.947,497.447,501.443,505.439,509.939,513.44,515.438,517.94,522.44,524.438,528.938,532.934" svgx:width="0.33,0.28,0.39,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.28,0.5,0.44,0.28,0.25,0.78,0.44,0.5,0.25,0.5,0.44,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.44,0.44,0.25,0.25,0.5,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">risk factor that may be safely applied in daily practice, needs to be </text>
   <text y="725.051" x="297.26,301.256,305.756,310.256,313.253,315.755,318.752,325.754,329.75,334.25" svgx:width="0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">confirmed.</text>
  </g>
 </g>
</svg>
